Healthcare Business
Latest News
SCOTUS temporarily allows firing of FTC's lone Democrat
The Supreme Court gave President Donald Trump a temporary green light on his removal of Rebecca Kelly Slaughter, one of two Democratic Federal Trade C...
Omada finds 6 in 10 members maintained weight loss after discontinuing GLP-1s
Despite the hype about weight loss drugs known as GLP-1s, serious questions have remained about their efficacy when patients wean off the drugs. To da...
Real-World Data Show 12-month Drug Survival Rates Among Anti-TNF Biosimilars in Psoriasis, PsA
A retrospective, long-term real-world study of 93 patients with psoriasis and psoriatic arthritis (PsA) treated with anti-tumor necrosis factor (TNF)-...
Connectivity: The missing link in payment infrastructure
In healthcare payments, speed matters. Scale matters. But connection matters most. It’s not about sending a faster ACH — it’s about building the infra...
The single source of truth for member risk: Breaking risk adjustment’s speed-accuracy-ROI trilemma
Your members are sicker than your risk scores reflect. Not because diagnoses don't exist—they're buried under unstructured data across fragmented syst...
WellSpan, General Catalyst expand partnership to test out and scale AI technologies
WellSpan Health, an eight-hospital health system, inked a partnership with General Catalyst three years ago to use technology to tackle staffing short...
Epic’s “Emmie” Chatbot Enhances the Patient Voice – For Their *Real* Customers – The Health Care Blog
By MICHAEL MILLENSON A Rock Health write-up of this year’s Epic Users Group Meeting captured the artificial intelligence vibe with a play on the names...
Evolving Roles of Antibody-Drug Conjugates in the Treatment of NSCLC
The treatment of non–small cell lung cancer (NSCLC) has changed dramatically in recent years with the rise of biomarker-driven targeted therapies and...
The Expanding Role of Antibody-Drug Conjugates in Breast Cancer Treatment: Oranus Mohammadi, MD
At a recent Institute for Value-Based Medicine® event, Oranus Mohammadi, MD, a medical oncologist and hematologist at The Oncology Institute in Los An...
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
Biomarker testing is a crucial step for those diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC), but nearly one-third of eligible...
SCOTUS temporarily allows firing of FTC's lone Democrat
Omada finds 6 in 10 members maintained weight loss after discontinuing GLP-1s
Real-World Data Show 12-month Drug Survival Rates Among Anti-TNF Biosimilars in Psoriasis, PsA
Connectivity: The missing link in payment infrastructure
The single source of truth for member risk: Breaking risk adjustment’s speed-accuracy-ROI trilemma
WellSpan, General Catalyst expand partnership to test out and scale AI technologies
Epic’s “Emmie” Chatbot Enhances the Patient Voice – For Their *Real* Customers – The Health Care Blog
Evolving Roles of Antibody-Drug Conjugates in the Treatment of NSCLC
The Expanding Role of Antibody-Drug Conjugates in Breast Cancer Treatment: Oranus Mohammadi, MD
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago